Northern Trust Corp Galera Therapeutics, Inc. Transaction History

Northern Trust Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$2.5 - $3.42 $99,407 - $135,989	39,763 Added 135.87%	69,029 $215,000
Q3 2022 Nov 14, 2022	BUY	$1.15 - $2.1 $12,754 - $23,291	11,091 Added 61.02%	29,266 $51,000
Q3 2021 Nov 15, 2021	BUY	$7.04 - $10.49 $23,795 - $35,456	3,380 Added 22.85%	18,175 $147,000
Q2 2021 Aug 13, 2021	SELL	$6.08 - $10.44 $487,312 - $836,766	-80,150 Reduced 84.42%	14,795 $145,000
Q1 2021 May 12, 2021	SELL	$8.35 - $12.39 $31,880 - $47,305	-3,818 Reduced 3.87%	94,945 $838,000
Q4 2020 Feb 11, 2021	SELL	$8.02 - $12.81 $41,559 - $66,381	-5,182 Reduced 4.99%	98,763 $1.01 Million
Q3 2020 Nov 16, 2020	SELL	$6.96 - $9.12 $1,670 - $2,188	-240 Reduced 0.23%	103,945 $940,000
Q2 2020 Aug 14, 2020	BUY	$7.14 - $14.41 $505,326 - $1.02 Million	70,774 Added 211.83%	104,185 $744,000
Q1 2020 May 14, 2020	BUY	$5.89 - $17.67 $2,597 - $7,792	441 Added 1.34%	33,411 $317,000
Q4 2019 Feb 14, 2020	BUY	$9.13 - $13.9 $301,016 - $458,283	32,970 New	32,970 $434,000

961K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.34M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.